Qyuns Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	499.32	360.69	216.3	213.09	218.06
Short-Term Investments	39.5	0.42	0.54	0.55	0.29
Trading Asset Securities	20.07	195.44	160.41	401.1	402.38
Cash & Short-Term Investments	558.9	556.55	377.26	614.73	620.72
Cash Growth	-11.23%	47.53%	-38.63%	-0.97%	-
Accounts Receivable	87.36	26.28	-	-	-
Other Receivables	-	0.6	0.36	4.04	8.65
Receivables	87.36	26.88	0.36	4.04	8.65
Inventory	32.8	3.34	3.77	-	-
Prepaid Expenses	-	24.52	23.03	16.23	18.45
Other Current Assets	-	5.44	13.91	0.94	0.44
Total Current Assets	679.06	616.73	418.33	635.95	648.26
Property, Plant & Equipment	321.22	334.06	361.44	386.16	400.83
Other Intangible Assets	2.9	3.47	2.35	3.05	0.38
Other Long-Term Assets	32.18	29.62	13.47	9.94	18.02
Total Assets	1,132	983.88	795.58	1,035	1,067
Accounts Payable	126.58	110.89	72.96	19.14	12.6
Accrued Expenses	26.54	33.37	31.01	24.64	19.04
Short-Term Debt	104.58	179.48	59.6	15.9	-
Current Portion of Long-Term Debt	81.76	31.1	60.1	44.61	14.87
Current Portion of Leases	1.41	1.42	1.29	1.75	0.96
Current Unearned Revenue	21.5	9.36	0.87	-	-
Other Current Liabilities	88.67	64.54	25.95	16.15	22.22
Total Current Liabilities	451.04	430.16	251.78	122.19	69.67
Long-Term Debt	447.77	315.12	224.43	232.52	274.05
Long-Term Leases	0.41	0.47	0.63	0.47	0.39
Long-Term Unearned Revenue	16.8	16.73	17.38	18.02	18.66
Long-Term Deferred Tax Liabilities	0.3	0.34	0.41	0.49	0.56
Total Liabilities	916.32	762.83	494.63	373.69	363.33
Common Stock	222.07	222.07	210.03	180.53	166.48
Additional Paid-In Capital	1,012	1,012	830.18	830.18	616.23
Retained Earnings	-1,285	-1,257	-921.36	-413.61	-115.42
Comprehensive Income & Other	277.09	251.37	175.91	44.62	3.06
Total Common Equity	226.36	228.98	294.76	641.72	670.35
Minority Interest	-10.53	-7.93	6.19	19.7	33.82
Shareholders' Equity	215.83	221.05	300.95	661.41	704.17
Total Liabilities & Equity	1,132	983.88	795.58	1,035	1,067
Total Debt	635.94	527.6	346.06	295.25	290.26
Net Cash (Debt)	-77.04	28.96	31.2	319.48	330.46
Net Cash Growth	-	-7.18%	-90.23%	-3.32%	-
Net Cash Per Share	-0.35	0.13	0.15	1.80	2.84
Filing Date Shares Outstanding	222.07	222.07	222.07	180.53	166.48
Total Common Shares Outstanding	222.07	222.07	210.03	180.53	166.48
Working Capital	228.02	186.56	166.55	513.76	578.59
Book Value Per Share	1.02	1.03	1.40	3.55	4.03
Tangible Book Value	223.45	225.5	292.42	638.66	669.98
Tangible Book Value Per Share	1.01	1.02	1.39	3.54	4.02
Buildings	-	238.61	238.73	238.73	238.73
Machinery	-	190.77	188.24	178.24	168.09
Construction In Progress	-	0.43	0.21	4.96	2.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.